Entering text into the input field will update the search result below

NantKwest's NK-92 bioanalytical testing line licensed to Fresenius Kabi SwissBioSim

Sep. 10, 2020 10:49 AM ETImmunityBio, Inc. (IBRX) StockBy: Vandana Singh, SA News Editor2 Comments
  • NantKwest's (NK +2.0%) affiliate and exclusively-licensed distributor of its proprietary off-the-shelf NK-92® natural killer cells, Brink Biologics, has licensed its natural killer-based bioanalytical testing solution, to Fresenius Kabi SwissBioSim.
  • Brink Biologics offers NK-92 based cell lines as part of its Neukopanel portfolio for laboratory based bioanalytical testing.

Recommended For You

About IBRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IBRX--
ImmunityBio, Inc.